Graphene and graphene oxide as nanomaterials for medicine and biology application

Abstract

Graphene- and graphene oxide-based nanomaterials have gained broad interests in research because of their unique physiochemical properties. The 2D allotropic structure allows it to be used in various biological fields. The biomedical applications of graphene and its composite include its use in gene and small molecular drug delivery. It is further used for biofunctionalization of protein, in anticancer therapy, as an antimicrobial agent for bone and teeth implantation. The biocompatibility of the newly synthesized nanomaterials allows its substantial use in medicine and biology. The current review summarizes the chemical structure and biological application of graphene in various fields.

Graphical abstract


Introduction

Graphene is formed by a thick sheet of carbon atoms bonded by sp 2 hybridization arranged in a hexagonal array. It has gained immense interest in various fields due to its unique electrochemical properties which include high thermal conductivity, high current, density, chemical inertness, optical transmittance and very high hydrophobicity [ 1 , 2 ]. It is the simplest form of carbon and the thinnest material produced so far [ 3 ]. It exists as few layers of graphite. X-ray diffraction technique reveals the crystal structure of graphene as a closely packed honeycomb-like structure [ 4 ] (Fig.  1 ). The graphene family includes members such as reduced graphene oxide (rGO), graphene oxide (GO) [ 5 ], graphene sheets and layered graphenes such as few layered graphenes and multilayered graphene (MLG) [ 6 , 7 ].

Fig. 1

a Chemical structure. b Crystal structure of graphene compound

Besides its availability in nature, its wide use has led us to synthesize it by two common methods: (1) the top-down and (2) the bottom-up method. In the top-down approach, layers of graphite are simply separated to get the graphene layer. But to do this, van der waals interaction between the layers need to be broken [ 8 ]. However, there are several challenges with this method such as defects in the surfaces may occur during the preparation of sheets of graphene and the discrete sheets cumulate subsequently. Generally, the top-down approach offers low yield and the process is very tedious [ 8 ]. In the bottom-up approach, carbon molecules which are procured from different origins are used as building blocks [ 9 ]. This approach is also not suitable for making graphene sheets with a huge surface area. At the time of fabrication of graphene, the most conventional method to synthesize graphene was the mechanical cleavage of graphite which produces high-quality, defect-free graphene [ 10 ]. An effective alternative method is chemical vapour deposition (CVD) [ 11 , 12 ]. It was observed that the above procedures are time-consuming and produce very low yields, but in the case of mechanical cleavage methods it helps in the effective and full exploitation of these materials [ 13 ]. The alternative method which is scalable, cost-effective and gives excessive yield is exfoliation of graphite or its derivatives like GO [ 14 ].

GO is obtained from a highly oxidized form of graphene molecule by using many strong oxidizing agents. Particularly, GO, due to its excellent surface functionability, amphiphilicity, aqueous appearance, fluorescence quenching ability and surface-enhanced Raman’s scattering property, is chemically exfoliated from other graphene derivatives [ 15 ]. These exceptional characteristics of GO is due to the small sp 2 carbon domains which are enclosed by sp 3 domains and the hydrophilic functional groups containing oxygen due to its distinctive chemical structure [ 16 ]. Hummer’s method is widely used to synthesize GO, as it includes oxidation of graphite by mixing the solution of graphite, potassium permanganate and sulphuric acid [ 17 ]. This exfoliation in solvents with sonication results in graphite salts, which act as a precursor for GO. The thermal and chemical reduction process of GO converts it to a graphene analog [ 14 ]. It has a wide application for filtration purposes, as this thin membrane has the property of filtering harmful gases but is permeable to water. GO is a mass of solid prepared by the process of oxidation of graphite through various chemical processes, which enlarge the interlayer spacing and the base planes. It can be peeled off in a solution to convert it to a monolayer or a few-layer form of GO [ 5 ].

rGO is synthesized from GO by thermal (photothermal), chemical (photochemical), microwave or different bacterial as well as microbial methods by reducing its oxygen amount (Fig.  2 ). It is widely used in the field of electronics to manufacture conductive ink circuits and fabrication of electronic devices [ 18 ]. The layered graphene is synthesized by the stacking of two-dimensional sheet-like GO in a small number (2–10), but the individual scrap should still maintain its high aspect ratio. This MLG has a wide application in the supplementation of mechanical engineering and in the manufacture of composite materials [ 6 ]. Among all the forms, GO has recently gained immense interest in biomedical applications.

Fig. 2

Conversion of graphene into GO and rGO

GO has unique intrinsic physical as well as chemical properties. Some of the chemical properties include large surface area, functionality containing oxygen, better conductivity and good biocompatibility. The chemical property allows it to be used in bioimaging, biosensing and hypothermia capabilities [ 19 ]. 2-D nanosheet graphene contains a single layer of carbon atom arranged hexagonally to increase the surface area, diameter, thickness, stiffness and conductivity. Graphene has specific catalytic, mechanical, electronic, thermal, biological and optical properties [ 7 , 20 , 2122 ], which allow it to be used for biomolecule recognition, bioassays, molecular medicine and small molecular drug delivery. The biocompatibility and quick functionalization make graphene an assuring platform in tissue engineering [ 23 ], molecular drug delivery [ 24 ], cancer treatment [ 25 ], biosensing [ 26 ], and bioimaging [ 27 ]. Graphene-based materials are used in the field of bone repair or organ regeneration. Both GO and rGO are utilized in osteogenic stem cells to study [ 28 , 2930 ] chondrogenesis [ 31 ], adipogenesis [ 32 ], epithelial genesis [ 32 ], myogenesis, cardiomyogenesis [ 33 , 34 ] and neurogenesis [ 35 ].

Graphene is utilized as a substrate interfacing with different cells and biomolecules. Modification of graphene enhances its compatibility, selectivity and solubility in a biological system [ 36 ]. Graphene is used for drug delivery [ 37 ], biomolecule recognition, bioassays and in molecular medicine. Graphene and its materials are extensively applied in antibacterial compositions [ 25 , 38 , 39 ], biosensing [ 40 ], energy storage [ 41 ], catalysis [ 42 ] and tissue scaffolds [ 28 ]. In this review, we have listed various uses of graphene and graphene-based materials in the biomedical field.

Biomedical applications of graphene

Graphene has been in the forefront of research since the past few years. Development of new methods of graphene synthesis has made this material easily available in the market. Along with graphene, its derivatives such as GO and rGO have gained much more interest in their application (Fig.  3 ).

Fig. 3

Biological application of graphene

Biofunctionalization with proteins

Graphene interacts with the protein, the building block of the body. It interacts either with the secondary structure, functional group or by physical adsorption. The charge status of the functional group is dependent on the environment such as ionic strength and pH value of the buffer, since the positive or negative charge of the proteins depends on the presence of carboxylate and protonated amino group, respectively [ 25 ]. The variation in the surface charge density of functional groups containing oxygen on GO determines its preparation and storage. The GO–oxygen containing groups, makes it acceptable for immobilization of biocatalysts with no surface adjustments and no coupling reagents [ 43 ]. Further, to monitor the protein absorption by using the channel of graphene as electrolyte gate, field effect transistor was built [ 25 ]. GO has been conjugated with gold-Ab and modified the traditional surface plasmon resonance. GO provides a larger surface area and abundant oxygen molecules as a functional group benefiting the method of immobilization and detection sensitivity [ 44 ]. Go-based biosensors have been also used to detect ssDNA, living cells and metal ions [ 45 ]. Thus, GO is used to immobilize several proteins. Lysozyme and horseradish peroxidase enzymes can be exhausted suddenly on the surface of GO [ 46 ]. Also, a microbial protein hydrophobin is used in the functionalization of GO [ 25 ]. Introduction of various metals such as Au, Ag, Pd and Pt with the graphene nanosheet has been reported [ 47 ]. The immobilization of enzymes on inorganic materials has proved to be a fruitful application, improving its stability under various conditions [ 48 ]. Nanomaterials such as magnetic GO are synthesized by covalent binding of amino Fe 3 O 4 onto GO and were used to immobilize laccase [ 49 ]. Compared to free laccase and immobilized laccase, the one immobilized showed higher thermal stability and various pH values [ 49 ]. Functional forms of graphene-immobilized naringinase have shown high isoquercitrin production. 92.24 ± 3.26% yield was found in microchannel reactor after 20 mins [ 50 ]. The Vm/Km kinetic parameter showed an increase to 1.9-fold and a 1/3rd decreased reaction time in a batch reactor. The result shows when the sheets of graphene are immobilized with an enzyme, the specificity increases and shows a mild catalytic characteristic so that the enzyme can be reused [ 49 ]. GO is applied for immobilization in the case of β-amylase. Functionalized sheets of GO were also modified on a matrix causing Fenugreek immobilization [ 51 ]. The affecting factors were analysed using SPR, SEM and TEM that showed an immobilization efficiency of 84% [ 51 ].

.Green fluorescent protein (EGFP) is a protein of 293 amino acids (32.7 kDa) and emits bright green fluorescence radiation when exposed to blue towards UV light. EGFP is biologically inert [ 52 , 53 ], and thus extensively used in the biological field to identify cells and tissue having target gene expression [ 54 , 55 ]. EGFP-tagged graphene has been synthesized as EGFP-rGO and used to study lactate dehydrogenase (LDH, which is present in all cells) leakage, a suitable index to check cytotoxicity based on the absence of integrity of membrane which mainly focuses on necrosis [ 56 ]. Incubation of cells with EGFP-rGO does not change its morphology, suggesting it as nontoxic for the cell. Thus, it can be used as a marker to study cytotoxicity and identification of cells or region of tissues having an expression of target genes [ 57 ]. It is used with highly specific proteins, for instance, biotin/avidin interaction or antigen antibody–antigen interaction.

GO–protein interaction is applied in protein crystallization. Obtaining a nucleus and controlling it as a prolific method for diffracting crystals of protein and solving its structure with the help of X-ray crystallography. Involving GO has proved to be fruitful in nucleation and graphene sheets offer a wider heterogeneity of surface along with multiple sized, ‘pockets (interparticle)’ where crystals of protein are able to nucleate [ 47 ].

Biofunctionalization with DNA

ssDNA along with graphene serves as a good surface-enhanced laser desorption/ionization time-of-flight mass spectrometry analysis platform; also, graphene embedded with DNA is used to form different nanoparticles and other biosystems. Thiol GO–DNA sheets can make a two-dimensional bionano interface to accumulate gold nanoparticles maintaining its optical properties [ 25 ]. FRET biosensor, based on graphene, includes fluorescein amidite-labelled ssDNA that are absorbed on the GO sheet. The application also includes molecular beacon fabricated to graphene-based FRET biosensors enhancing its DNA detection property.

Gene delivery

Gene delivery is a method of introducing foreign DNA into the cell. It is an alternative approach to cure various genetic diseases. Modified GO is used for gene delivery purposes. Polyethylenimine (PEI) modifies the surface of GO sheets and thus makes it ready for cellular gene delivery through covalent conjugation and electrostatic interaction [ 58 ] for plasmid DNA (pDNA) stacking. GO is attached covalently to the linear chain [ 35 ] and branched chain [ 59 ]. PEI is thus used for high-quality transfection effectiveness containing low cytotoxicity than pDNA/PEI complexes. Thus, it has an upper hand over PEI/pDNA complexes. As of date, chitosan-complexed GO (CS–GO) has been integrated. This complex is used for productive delivery of anticancer medication and plasmid DNA stacked individually simultaneously by electrostatic and ππ interaction [ 60 ].

Small molecule drug delivery

The presence of the proteolytic enzymes present in the cytoplasm often interferes in the drug delivery process. GO is used in case of effective gene and drug delivery acting as a carrier (Fig.  4 ). The functional group (COOH and OH) of GO allows it to conjugate with various polymers and biomolecules (ligand, DNA, protein).

Fig. 4

Graphene as a carrier for target (gene or small molecular drug) delivery

Approaches include its functionalization with cationic polymer, for example PEI [ 24 ]. It is used as a non-viral gene vector as it can strongly interact with the negatively charged phosphate ions of DNA and RNA [ 24 ]. It makes transfection easy and efficient, improves cell selectivity and reduces cell toxicity. The use of PEI-functionalized GO delivery of antiapoptotic family protein Bcl-2-targeted siRNA and anticancer drug DOX exhibited a synergistic effect offering a higher transfection efficacy with decreased cytotoxicity of PEI and enhanced anticancer efficacy [ 61 ]. A photochemically controlled gene delivery carrier has also been developed where PEI of low molecular weight and rGO are conjugated with polyethylene glycol (PEG) of hydrophilic nature and was confirmed to be stable with plasmid DNA by physiochemical assays [ 57 ]. FeO nanoparticles provided GO with multifunctionality and multimodality for assorted organic and medicinal applications [ 62 ]. Antiinflammatory drug delivery of ibuprofen has been reported by applying chitosan-containing GO [ 35 ].

The unmodified basal plane sites of graphene that has free surface π electrons are hydrophobic and are capable of forming ππ interactions for loading drug as well as covalent modifications [ 63 , 64 ]. Some of the drug delivery occurs due to the change in temperature, pH, light and salt concentration. Polymers can detect the change in the surroundings and the drug is delivered. GO biopolymers are sensitive towards pH and thus also used as a transporter for smart drug delivery. For instance, doxorubicin (DOX)–GO compound indicated the appearance of DOX from GO which is pH sensitive because of DOX’s higher solvency at low pH [ 65 ]. Considering this point of interest, pH-sensitive delivery was effectively exhibited in case of DOX and camptothecin by utilizing folic acid consisting of nano-GO (NGO), called FA–NGO to treat tumours [ 44 ]. Ibuprofen and 5-fluorouracil drugs, having antiinflammatory property with distinctive hydrophilicity, were likewise delivered by utilizing the CS–GO complex with a pH-dependent release [ 66 ]. GO is modified as a carrier for delivering cancer drugs that are water soluble. The solubility in the physiological and aqueous solutions can be increased by the functionalised NGO with PEG [ 47 ].

Biosensing and bioimaging

Derivatives of graphene, including GO, artificially reduce GO (rGO) [ 66 ], and doped graphene [ 66 ] has been studied to know its universal implementations in biodetecting and biosensing for biomolecules such as thrombin [ 67 ], oligonucleotides [ 68 ], ATP [ 46 ], amino corrosives [ 69 ] and dopamine [ 70 ]. Nowadays, various biosensors-based GO have been produced, such as: (1) utilization of fluorescence quenching capacity of graphene which is supereffective and few FRET-based biosensors have been created [ 50 , 67 ]; (2) FRET-based biosensors of graphene have been created on the basis of their electric property [ 71 ].

Self-assembling and controllable graphene biomolecules permit assembling ultrasensitive biosensors for recognition of DNA and different atoms [ 72 , 73 ]. GO-based biosensors have been developed by taking advantage of their unique physiochemical properties such as extensive surface region, great electrical conducting ability and the magnificent ability for stacking different biomolecules by means of chemical or physical association [ 73 , 7475 ].

Multilayered ultrathin graphene films, assembled by using layer-by-layer assembly technique, showed catalytic activity against reduced H 2 O 2 . Graphene–ultrathin films stimulate the production of advanced biosensing and electrochemical sensors [ 76 ].

Cancer treatment

Graphene is used to detect early stage of cancer cells [ 77 ]. With the tumour sphere assay, the functionality as well as the clonal expansion of the anchorage-independent single cancer stem cell can be measured [ 77 ]. GO restricts the formation of tumour sphere effectively in various cell lines that include ovarian, pancreatic, breast, lung cancers and glioblastoma. It is astonishing that GO is less toxic for cancer cells than normal fibroblastic cells. GO therapy inhibits Notch and Wnt driven signal pathways and STAT1/3 signalling, and antioxidant response depends on NRF2. It was reported that in cancer cells, GO induces the responses of toll-like receptors and can cause autophagy [ 78 ] and antitumour effects. CT26 colon cancer cells engulf the GO, and on the other hand trigger TLR-4 [ 79 ], TLR-9 signalling pathways and autophagy. GO when injected into mice (immunocompetent) having CT26 colon cancer cells [ 78 ] not only prevent the progression of tumour, but also induces autophagy [ 80 ], immune responses and cell death [ 81 ]. For effective hydrophobic medication (drugs) delivery, NGO is functionalized having six-arm polyethylene glycol and efficiently connected to tumour cell lines having therapeutic efficacy [ 37 , 82 ] along with a high cell uptake. Conjugate PEG–GO exhibited malignancy in xenograft models and thus have high therapeutic value [ 83 ]. Presently, it has been considered that due to oxidative stress induction and depolarization of mitochondria, caspase activation bringing about necrotic and apoptotic cell death [ 84 ], the phototherapeutic impact of NGO subordinates occurs. For improvement of therapeutic adequacy, PEG–GO was utilized as a transporter for photothermal, DOX and chemical therapy [ 63 ]. Graphene/TiO 2 nano-hybrid composites additionally indicated high restorative ability which depends on the photocatalytic [ 33 ] and photothermal therapy. PEGylated GO utilizing xenograft tumour models of the mouse has shown higher uptake of PEG-modified GO by tumour cells, because of exceptionally productive tumour targeting of GO brought on by enhanced permeability and retention effect [ 83 ]. The nanosheet which is a hybrid mixture of GO and gold nanoparticles (AuNPs) easily adheres on the cell surface and promotes a type of cancer therapy by the mechanism of photothermal effect [ 85 ].

Substrates for antibacterial effects

Silver nanoparticle preparation and antibacterial effect on GO sheets have been reported [ 86 ]. GO has been geared up in the presence of sodium citrate and silver nitrate. Characterization of GO was done physicochemically by using thermogravimetric analysis (TGA), XRD, TEM, UV–Vis and Raman’s spectroscopy. Using the standard counting plate methodology, the antibacterial property of GO and GO–Ag against microbes was observed. Dispersion of GO showed negligible antimicrobial activity against the microorganism and GO–Ag compound showed an increased antibacterial activity. The activity for antibiofilm was also observed on Pseudomonas   aeruginosa , on a stainless steel surface showing 100% inhibition rate when exposed to the GO–Ag nanocomposite [ 87 , 88 ]. Bao et al. [ 89 ] had a similar result using a disc diffusion test and evaluated the antibacterial property of GO by observing an inhibition zone surrounding the GO disc showing toxicity of bacteria against Staphylococcus aureus and Escherichia.coli . However, the GO–Ag compound resulted in P. aeruginosa inhibition [ 67 ]. The GO–Ag sample hinders P. aeruginosa growth [ 67 ]. The RGO and GO-based paper/sheet has the ability to inhibit both Gram-negative and Gram-positive bacterial growth [ 25 ]. Graphene derivatives show antibacterial impact because of layer disruption [ 90 ]. Since it is cost-effective, it opens a new door in clinical and ecological applications of GO [ 29 ]. If we compare with GO, Gt, rGO and GtO graphene subordinates, it has been found out that the antibacterial property diminishes in them as we move towards GtO.

GO and rGO show more prominent antibacterial activity than others [ 38 , 91 ] by causing membrane stress. The stress is generated by the pointed uneven corner of graphene, which leads to cell membrane damage, ejaculation of RNA and membrane integrity loss [ 92 ]. When the concentration, incubation time and the conditions are same, GO shows the highest antibacterial activity as rGO, Gt and then GtO. The antimicrobial mechanism of carbon nanotubes, such as (1) deposition of the cell on materials which are graphene based, (2) membrane stress when sharp nanosheets directly contact cells of the body and (3) oxidation, independent of superoxide anion, is suited for materials based on graphene. The bacterial activity of GtO is much stronger in comparison to GO [ 39 ]. Although graphene-based materials produce trace amount of ROS, the minor antibacterial activity of GtO is not negligible [ 86 ].

Scaffolds for mammalian cell culture

The CVD substrate of graphene is biologically compatible with human mesenchymal cells (hMSCs) and human osteoblasts. Cell lines grown in the presence of graphene show higher rate of proliferation, growth and differentiation [ 93 ] in comparison to the SiO substrate [ 6 , 94 , 95 ]. It has been reported that the use of different GO materials for cell cultures of lung epithelium have no impact on the viability and biological response of the cell [ 96 , 9798 ]. NIH-3T3 fibroblasts behaviour was studied in different substrates covered with carbon nanomaterial, for example, GO, carbon nanotubes and RGO. The substrates coated with carbon nanomaterial had enhanced gene transfection efficiency and high biocompatibility [ 99 ]. Graphene/chitosan films demonstrated promising application to enhance and repair tissue functions in tissue engineering [ 100 ]. CVD-developed graphene substrate has also proved to be biocompatible for hMSCs and also for human osteoblasts with a higher rate of expansion of cell and stimulating the development and differentiation of cells [ 94 ]. Multilayered GO nanosheet assembled by layer-by-layer technique can improve the mechanical properties of polyelectrolyte multilayer films for better attachment of cells [ 101 ].

Differentiation of stem cells

A noble platform of development for growth and differentiation of neuronal stem cell is an important norm for autologous tissue engineering and cell therapy to treat neurodegenerative diseases as well as neuronal disorders. Graphene is utilized for stem cells culture. Recently, human mesenchymal stem cell neuronal differentiation (hMSCs) was seen on the surface of graphene, as it supports a cell-adhesive coat bearing electrifying coupling impact for stimulation of stem cell differentiation [ 102 ]. Likewise, graphene additionally improved the differentiation of bones in comparison to regular growth factor [ 28 ]. Graphene provides an environment in which mesenchymal stem cells of a human (hMSCs) are organized in a 3D spheroids manner, essential to produce neurons from hMSCs. The monolayer of graphene regulates human mesenchymal stem cells (hMSCs) growth and development [ 103 ]. Substrates coated by GO increase embryonic stem (ES) cell differentiation in mouse into haematopoietic cells [ 104 ]. Graphene foam, a porous 3-D structure is being used in the energy conversion/storage system and electronics, areas of tissue engineering, to construct a scaffold of neural stem cell as it predominant to traditional inert biomaterials [ 105 ].

Graphene in biomedical implantation

In the last few decades, a lot of new therapies and devices based on materials have been discovered for the treatment of various diseases. New metallic alloys such as stainless steel and Nitinol (NiTi) have often been used in biomedical implants because of their advanced mechanistic properties [ 106 ]. Although there are major concerns regarding their use due to their exogenous cytotoxicity, these metallic alloys lack cellular adhesion. However, these may interact with proteins or other living cells leading to a strong immunological reaction that may affect the device functionality [ 106 , 107108 ]. The unique properties of graphene along with its ability to form conjugates with other molecules due to the availability of a high number of functional groups gives an opportunity to create biocomposites with modified properties.

Graphene-based materials play vital roles in bone and tissue engineering. Regeneration of the bone tissues and their mineralization are the important factors in the process of reconstruction of bone defects [ 109 ]. One of the most commonly used strategies is the use of grafts, as spontaneous regeneration is not always feasible. Due to the high cost of grafting [ 110 ] and some of the disadvantages like lack of viable cells, the risk of immunogenicity and infection transmission, synthetic bone substitutes based on ceramic [ 111 ] are used in clinical practice [ 112 ]. Graphene and its derivatives, when combined with ceramics, give rise to materials having enhanced mechanical as well as osteogenic properties. HAp, a commonly used material, has been combined with graphene for enhanced capabilities [ 113 , 114 ]. The addition of chitosan or PEG to HAp/GO nanocomposite can release the considerably high amount of calcium and phosphorus ions as compared to only HAp [ 114 , 115 ]. Several improvements have been observed in the mechanical and physical properties when graphene is combined with HAp. The addition of GO to the coating of HAp increases the strength [ 116 ]. Moreover, the coating with modified GO offered resistance to corrosion and it was also possible to increase the elastic module of HAp and fracture toughness [ 117 , 118 ]. Incorporation of GO nanoflakes in the scaffolds of gelatin and HAp produced compressive strengths and the yield was also increased compared to gelatin/HAp [ 119 ].

Graphene improves the functionality of HAp. Certain glass–ceramic reactive materials also have the ability to bind to bones and they are biodegradable as well [ 120 ]. Addition of 0.5 wt% of graphene into 58S bioglass via laser sintering increases the fracture toughness and strength [ 121 ]. Notably, the properties of HAp and bioglass can be influenced by rGO which depends on the concentration. The improvements of mechanical properties of the bioceramic materials by graphene and other related materials are done by bridging, sheet pullout and three-dimensional crack deflection mechanisms [ 118 , 122 , 123 ]. The graphene has a surface area for contact. Thus, graphene-modified bioceramics often have enhanced bioactivity. In a culture of mesenchymal cells (MSC) dispersed in a colloidal solution of HAp coated with rGO, elevated alkaline phosphates activity (ALP) and deposition of nodules of calcium than HAp or rGO alone were shown. Moreover, the cells also showed a high expression level of osteopontin and osteocalcin that play important roles in bone mineralization [ 124 ]. As osteocalcin is expressed in late stages of differentiation of osteoblasts [ 125 ], it is likely that the rGO/HAp composite promotes differentiation of these cells [ 124 ]. Other osteoconductive bioceramics like calcium phosphate as well as β-tricalcium phosphate (β-TCP) can be mixed with graphene to improve its in vitro bioactivity. In in vitro studies, GO/β-TCP composite elevated the activity of ALP and also the osteogenic related gene expression in MSCs of bone marrow. GO-modified scaffolds also increase the expression level of Wnt cell signalling pathway proteins, suggesting the role of this pathway in the differentiation of osteoblasts [ 126 ]. Graphene-mediated enhancements in the differentiation of osteoblasts is also seen in vivo. Calvarial defects of critical sizes were produced in rabbits and then cured with GO/β-TCP scaffold, which resulted in higher rate of naive bone formation than defects filled by unchanged β-TCP alone [ 126 ]. Similar observations were also found in the case of rGO/HAp graft which showed considerably higher (52%) bone density than HAp (26%) as well as untreated control (17%) [ 127 ].

Polymeric substances have wide use in dentistry and biomedical field [ 128 ]. However, some of the polymer-based materials used in regenerative and reconstructive dentistry are poorly suited for areas that bear the load and may induce inflammatory responses. Moreover, the degradation of these materials may cause induction of an autocatalytic ester breakdown that lowers the pH, which is not suitable for cell viability [ 129 , 130 ]. These limitations can be overcome by blending the polymers with graphene and its derivatives for the production of composites with improved capabilities. Graphene is a potential candidate for coating of the implants. Nnitinol coated with graphene (Gr–NiTi) supports the excellent growth of endothelial cells and smooth muscle with better cell proliferation and no significant cytotoxic properties [ 131 ].

Graphene-based materials are used extensively in dental implants [ 132 ]. A crucial aspect of dental implants is the appropriate measure of the prevention of mechanical failure after implantation. Studies have found that silicatized titanium plates have higher bond strength and good adhesion with a carbon–graphite fibre-reinforced polymer [ 133 ]. An important challenge with the dental implants is the formation of biofilms and aggregation of microbial agents on the surface of the implant. To overcome this, researchers have tried various coating materials with antibacterial properties. A coating of artificial acrylic teeth surface with graphene and zinc oxide nanocomposite decreases the deposition of cariogenic Streptococcus mutans bacteria and biofilm formation [ 23 ]. PCL/graphene was the material preferred for the production of porous scaffolds [ 134 ]. One of the concerns is how to improve the osseointegration of a dental implant. Numerous efforts have been made to enhance the osseointegration property by promoting the attachment, differentiation and proliferation of bone-forming cells on the implant surface [ 132 ].

Photothermal therapy

A phototherapy is a useful approach that can treat a variety of diseases. In addition to gene therapy and chemotherapy, phototherapy also has the ability to control the progression of disease by irradiation of specific light that includes photothermal as well as photodynamic therapy (PTT, PDT). In PTT, a light-absorbing agent is used that generates heat when irradiated by light [ 135 ]. Exposure of biological tissues to such temperature results in destruction of the abnormal cells [ 136 ]. Based upon this in the field of phototherapy, they can absorb light strongly near the infrared region and have a large surface area with a high number of functional groups [ 137 ]. Liu et al. first reported the combined use of GO with PTT in successful tumour suppression [ 83 ]. DOX-loaded PEGylated NGO can deliver the drug to the tumourigenic region along with the heat that is generated to facilitate combined chemotherapy and photothermal treatment [ 138 ]. This approach is more useful than chemotherapy or photothermal treatment alone. Hu et al. developed rGO-tagged quantum dot (QD-CRGO) nanocomposite, which combines PTT therapy with fluorescence bioimaging of the cell/tumour. GO functionalized with biocompatible porphyrin was used as a platform for PTT of brain cancer. This PGO was found to be more stable than rGO and more, importantly, PGO caused depletion of a high number of brain cancer cells in vitro [ 139 ]. However, PTT alone cannot be used as such to destroy tumour cells as the heat is heterogeneously distributed in these cells [ 140 ]. PTT is used in combination with other strategies which may involve the modification of GO properties to enhance the therapeutic efficiency.

In PDT, a photosensitizer (PS) is irradiated with suitable light to generate free radicals and/or ROS that irreversibly damages the cancer cells [ 141 ]. Hypocrellin-A (HA, a hydrophobic perylenequinonoid anticancer drug having photodynamic properties) was immobilized on GO with the help of ππ interaction, hydrogen bonding and hydrophobic interaction [ 142 ]. The excitement of GO–HA at a particular wavelength of light generates singlet oxygen. High cellular uptake of GO–HA was revealed using HeLa cells and significant cell death by irradiation of light was also evident from the studies. Tian et al. showed the benefits of photothermal therapy with photodynamic treatment [ 86 ]. Chlorine6 (Ce6, a photosensitizer molecule) was loaded on PEGylated GO and the composite was delivered to KB cells (HeLa derivative cells). It was found that the delivery of Ce6 was promoted by a low power density laser (808 nm) by mild local heating due to the graphene, which has a photothermal effect. PDT is still a challenge, as the frequently used photosensitizers are hydrophobic.

Graphene in mass spectrometry

The properties of graphene, like large surface area, high thermal conductivity stability and the ability to interact with a variety of small molecules, allow it to be used widely in analytical chemistry based on mass spectrometry [ 143 ]. Derivatives of graphene are considered as useful matrices that can be replaced with organic matrices that are used conventionally for laser desorption–ionization mass spectrometry (LDI-MS), as they are very efficient in absorbing and transferring energy to the analytes [ 15 ]. The efficacy of graphene is much higher than that of GO and rGO, because of its electron transfer and high heat dissipation properties [ 144 ]. The hydrophobic properties of graphene make the affinity probe of LDI-MS more suitable for analysis of trace amounts of analytes having an aromatic structure which includes proteins [ 144 ], ssDNA, small molecules [ 69 ] and pollutants [ 145 ]. The unique properties of graphene make it an excellent absorbent in solid-phase extraction.

Graphene can be used as a good detection platform for ssDNA was first proposed by Tang et al. [ 144 ]. They found that with the help of graphene, very low limits of detection can be achieved for DNA as well as protein samples. Dong et al. found that the MALDI-MS of low molecular weight substances uses graphene as a matrix [ 69 ]. Detection of both polar compounds such as amino acids nucleosides and others as well as non-polar compounds such as steroids can be possible. The new matrix has the potential to eliminate the interference of matrix background ions, avoid the fragmentation of analytes and also improve shot-to-shot reproducibility. Later, Lu et al. introduced the use of graphene flakes as a very effective matrix for analysis of large-scale small molecules, which include peptides and fatty acids [ 146 ]. According to this study, graphene can be used to characterize polymers with average molecular weights from 425 to 3500 kDa. Graphene matrix can minimize the reduction of some redox-sensitive molecules such as methylene blue and riboflavin in MALDI [ 147 ]. Compared with conventional organic matrixes and other nano-sized inorganic matrixes, graphene matrixes show some important advantages, which include interference-free low molecular mass region, reduced spot-to-spot difference, high salt tolerance, great ability in negative ion mode and minimization of the reduction of redox-sensitive molecules [ 143 ].

Conjugation of the aptamer to GO makes it suitable to be used as specific affinity probe [ 91 ]. GO can also be used as a supporting matrix for the synthesis of Fe 3 O 4 nanocomposites for increased separation of sulphonamide antibiotics with magnetic retrieval of graphene [ 148 ]. TiO 2 -conjugated GO nanocomposites enhance the binding of phosphorylated biomolecules [ 149 ]. Moreover, GO-based monohybrid films were synthesized to increase the efficiency of LDI by immobilizing GO on a solid surface and then multiwalled carbon nanotubes(MWCNT) and gold nanostructure were incorporated subsequently [ 150 , 151 ]. The GO–MWCNT composite showed high potential for analysis of phospholipase activity by LDI-MS [ 152 ] along with other small molecules and tissue imaging [ 153 ]. The efficiency of LDI-MS using GO–MWCNT platform can be increased further by increasing the thickness and roughness of the surface [ 154 ].

A functional graphene paper was made using a pulsed laser engineering approach by spreading graphitic nano-spheres homogenously and used for matrix-free mass spectrometry. This technique increases the stability of the graphene paper as well as its hydrophobicity and electric conductivity. It also increases the imaging of trace element of small molecules and the detection limit is also increased twofold compared to other commercial products [ 155 ]. As a very elemental form of graphene, 2D graphene has high compatibility and duration needed for many imaging mass spectrometry (IMS) experiments.

Graphene has a great potential as an adsorbent in solid-phase extraction due to its properties, where it can play the dual role of an extractor and matrix in a MALDI-based MS analysis [ 143 ]. After the absorption and enrichment of the analyte from a complex sample mixture, it is very important to separate graphene from the mixture. With the help of centrifugation, graphene pellets can be collected after removing the supernatant [ 144 ]. Sometimes, it is necessary to wash the graphene after separation, which is done by water or some other solvents [ 156 , 157 ]. To minimize the loss of graphene, magnetic graphene can be prepared by combining Fe 3 O 4 or cobalt particles with graphene sheets [ 91 , 156 , 158 ].

Future uses of graphene

The nanomaterial based on graphene has been widely used in nonmedical fields since the last decade. Recently from a number of publications, we have evidence that graphene is attracting the attention of biomedical scientists. The wide range of applications in the delivery of gene/drug has exploited various properties of graphene such as ππ stacking and the loading of small molecular drugs on two-dimensional plane surface by hydrophobic interactions. The utilization of free π electrons, which disclose a negative charge on the surface, has been used to precipitate proteins and genes. GO surfaces enable possibilities for covalently linked and chemically assorted small molecules and similar proteins [ 105 ]. Although the research on graphene and its derivatives is at its early stage, in the upcoming days it will provide wide applications for biomaterial science and regenerative medicines [ 95 , 159 , 160 ]. Besides its wide application, the toxic effect of graphene has been recently reported from various studies. The future approach may be to nullify the toxic effect without affecting the physical and chemical properties [ 161 ].

Conclusion

Graphene and graphene-based composite have exclusive electronic, biological, mechanical, as well as unique optical properties. Researchers nowadays have developed various transistors based on graphene molecules, for use in the biomedical field such as biosensing via fluorescence, cell growth and its differentiation for the treatment of many diseases. The formation of a unique biosensor based on graphene has strong functionalization under various physiological conditions with a loss in few properties. As an emerging field, research on nanomaterial scaffolds of graphene for the implementation of stem cell culture deserves notable attention. To build therapeutics on the basis of graphene, researchers might standardize its derivatives as well as check functionalization of this on the biological field to know the response of cells to many graphene derivatives. Graphene may come up as a unique nanoparticle to be used in the biomedical study by efficient association with various branches of science.


Acknowledgements

SP and SM are thankful to MHRD for financial support. SB is thankful to Odisha DBT for financial support. This work is supported by DBT–Government of India to MM via grants no BT/PR21857/NNT/28/1238/2017.


Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


References

  1. Chen et al. (2008) Intrinsic and extrinsic performance limits of graphene devices on SiO2 3(4) 10.1038/nnano.2008.58
  2. Choi et al. (2010) Synthesis of graphene and its applications: a review 35(1) (pp. 52-71) 10.1080/10408430903505036
  3. Geim and Novoselov (2007) The rise of graphene 6(3) 10.1038/nmat1849
  4. Allen et al. (2009) Honeycomb carbon: a review of graphene 110(1) (pp. 132-145) 10.1021/cr900070d
  5. Compton and Nguyen (2010) Graphene oxide, highly reduced graphene oxide, and graphene: versatile building blocks for carbon-based materials 6(6) (pp. 711-723) 10.1002/smll.200901934
  6. Acik et al. (2010) The role of intercalated water in multilayered graphene oxide 4(10) (pp. 5861-5868) 10.1021/nn101844t
  7. Sanchez et al. (2011) Biological interactions of graphene-family nanomaterials: an interdisciplinary review 25(1) (pp. 15-34) 10.1021/tx200339h
  8. Edwards and Coleman (2013) Graphene synthesis: relationship to applications 5(1) (pp. 38-51) 10.1039/C2NR32629A
  9. Unknown ()
  10. Novoselov et al. (2004) Electric field effect in atomically thin carbon films 306(5696) (pp. 666-669) 10.1126/science.1102896
  11. Reina et al. (2008) Large area, few-layer graphene films on arbitrary substrates by chemical vapor deposition 9(1) (pp. 30-35) 10.1021/nl801827v
  12. Dato et al. (2008) Substrate-free gas-phase synthesis of graphene sheets 8(7) (pp. 2012-2016) 10.1021/nl8011566
  13. Verdejo et al. (2011) Graphene filled polymer nanocomposites 21(10) (pp. 3301-3310) 10.1039/C0JM02708A
  14. Park and Ruoff (2009) Chemical methods for the production of graphenes 4(4) (pp. 217-224) 10.1038/nnano.2009.58
  15. Chung et al. (2013) Biomedical applications of graphene and graphene oxide 46(10) (pp. 2211-2224) 10.1021/ar300159f
  16. Loh et al. (2010) Graphene oxide as a chemically tunable platform for optical applications 2(12) 10.1038/nchem.907
  17. Gao (2015) (pp. 61-95) Springer 10.1007/978-3-319-15500-5
  18. Li et al. (2010) All-carbon electronic devices fabricated by directly grown single-walled carbon nanotubes on reduced graphene oxide electrodes 22(28) (pp. 3058-3061) 10.1002/adma.201000736
  19. Liu et al. (2011) Carbon materials for drug delivery and cancer therapy 14(7–8) (pp. 316-323) 10.1016/S1369-7021(11)70161-4
  20. Jiang et al. (2007) Quantum Hall states near the charge-neutral Dirac point in graphene 99(10) 10.1103/PhysRevLett.99.106802
  21. Rao et al. (2009) Graphene: the new two-dimensional nanomaterial 48(42) (pp. 7752-7777) 10.1002/anie.200901678
  22. Marcano et al. (2010) Improved synthesis of graphene oxide 4(8) (pp. 4806-4814) 10.1021/nn1006368
  23. Kulshrestha et al. (2014) A graphene/zinc oxide nanocomposite film protects dental implant surfaces against cariogenic Streptococcus mutans 30(10) (pp. 1281-1294) 10.1080/08927014.2014.983093
  24. Goenka et al. (2014) Graphene-based nanomaterials for drug delivery and tissue engineering (pp. 75-88) 10.1016/j.jconrel.2013.10.017
  25. Wang et al. (2011) Graphene and graphene oxide: biofunctionalization and applications in biotechnology 29(5) (pp. 205-212) 10.1016/j.tibtech.2011.01.008
  26. Kuila et al. (2011) Recent advances in graphene-based biosensors 26(12) (pp. 4637-4648) 10.1016/j.bios.2011.05.039
  27. Shen et al. (2012) Graphene quantum dots: emergent nanolights for bioimaging, sensors, catalysis and photovoltaic devices 48(31) (pp. 3686-3699) 10.1039/c2cc00110a
  28. Nayak et al. (2011) Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells 5(6) (pp. 4670-4678) 10.1021/nn200500h
  29. Crowder et al. (2013) Three-dimensional graphene foams promote osteogenic differentiation of human mesenchymal stem cells 5(10) (pp. 4171-4176) 10.1039/c3nr00803g
  30. Lee et al. (2011) Origin of enhanced stem cell growth and differentiation on graphene and graphene oxide 5(9) (pp. 7334-7341) 10.1021/nn202190c
  31. Yoon et al. (2014) Dual roles of graphene oxide in chondrogenic differentiation of adult stem cells: cell-adhesion substrate and growth factor-delivery carrier 24(41) (pp. 6455-6464) 10.1002/adfm.201400793
  32. Kim et al. (2013) Bioactive effects of graphene oxide cell culture substratum on structure and function of human adipose-derived stem cells 101(12) (pp. 3520-3530) 10.1002/jbm.a.34659
  33. Lee et al. (2014) Graphene enhances the cardiomyogenic differentiation of human embryonic stem cells 452(1) (pp. 174-180) 10.1016/j.bbrc.2014.08.062
  34. Park et al. (2014) Graphene-regulated cardiomyogenic differentiation process of mesenchymal stem cells by enhancing the expression of extracellular matrix proteins and cell signaling molecules 3(2) (pp. 176-181) 10.1002/adhm.201300177
  35. Li et al. (2013) Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells 10.1038/srep01604
  36. Ghuge et al. (2017) Graphene: a comprehensive review 18(6) (pp. 724-733) 10.2174/1389450117666160709023425
  37. Sun et al. (2008) Nano-graphene oxide for cellular imaging and drug delivery 1(3) (pp. 203-212) 10.1007/s12274-008-8021-8
  38. Akhavan and Ghaderi (2010) Toxicity of graphene and graphene oxide nanowalls against bacteria 4(10) (pp. 5731-5736) 10.1021/nn101390x
  39. Perreault et al. (2015) Antimicrobial properties of graphene oxide nanosheets: why size matters 9(7) (pp. 7226-7236) 10.1021/acsnano.5b02067
  40. Lu et al. (2009) A graphene platform for sensing biomolecules 121(26) (pp. 4879-4881) 10.1002/ange.200901479
  41. Wang et al. (2009) Graphene oxide as an ideal substrate for hydrogen storage 3(10) (pp. 2995-3000) 10.1021/nn900667s
  42. Song et al. (2010) Graphene oxide: intrinsic peroxidase catalytic activity and its application to glucose detection 22(19) (pp. 2206-2210) 10.1002/adma.200903783
  43. Zhang et al. (2010) Graphene oxide as a matrix for enzyme immobilization 26(9) (pp. 6083-6085) 10.1021/la904014z
  44. Zhang et al. (2013) A novel surface plasmon resonance biosensor based on graphene oxide decorated with gold nanorod–antibody conjugates for determination of transferrin (pp. 230-236) 10.1016/j.bios.2013.02.008
  45. Dong et al. (2010) Fluorescence resonance energy transfer between quantum dots and graphene oxide for sensing biomolecules 82(13) (pp. 5511-5517) 10.1021/ac100852z
  46. Shao et al. (2010) Graphene based electrochemical sensors and biosensors: a review 22(10) (pp. 1027-1036) 10.1002/elan.200900571
  47. Zhang et al. (2011) Interaction of peptides with graphene oxide and its application for real-time monitoring of protease activity 47(8) (pp. 2399-2401) 10.1039/C0CC04887A
  48. Takahashi et al. (2000) Catalytic activity in organic solvents and stability of immobilized enzymes depend on the pore size and surface characteristics of mesoporous silica 12(11) (pp. 3301-3305) 10.1021/cm000487a
  49. Chen et al. (2017) Enhanced performance of magnetic graphene oxide-immobilized laccase and its application for the decolorization of dyes 22(2) 10.3390/molecules22020221
  50. Gong et al. (2017) Moving and unsinkable graphene sheets immobilized enzyme for microfluidic biocatalysis 7(1) 10.1038/s41598-017-04216-4
  51. Srivastava et al. (2014) Functionalized graphene sheets as immobilization matrix for fenugreek β-amylase: enzyme kinetics and stability studies 9(11) 10.1371/journal.pone.0113408
  52. Grigorenko et al. (2017) Molecular modeling clarifies the mechanism of chromophore maturation in the green fluorescent protein 139(30) (pp. 10239-10249) 10.1021/jacs.7b00676
  53. Rafat et al. (2010) PEG–PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells 31(12) (pp. 3414-3421) 10.1016/j.biomaterials.2010.01.031
  54. Bindels et al. (2017) mScarlet: a bright monomeric red fluorescent protein for cellular imaging 14(1) 10.1038/nmeth.4074
  55. Tschopp and Duboule (2014) (pp. 89-102) Springer
  56. Unknown ()
  57. Gurunathan et al. (2014) Enhanced green fluorescent protein-mediated synthesis of biocompatible graphene 12(1) 10.1186/s12951-014-0041-9
  58. Feng et al. (2011) Graphene based gene transfection 3(3) (pp. 1252-1257) 10.1039/c0nr00680g
  59. Rana et al. (2011) Synthesis and drug-delivery behavior of chitosan-functionalized graphene oxide hybrid nanosheets 296(2) (pp. 131-140) 10.1002/mame.201000307
  60. Bao et al. (2011) Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery 7(11) (pp. 1569-1578) 10.1002/smll.201100191
  61. Jaeger et al. (2012) Branched and linear poly (ethylene imine)-based conjugates: synthetic modification, characterization, and application 41(13) (pp. 4755-4767) 10.1039/c2cs35146c
  62. Kim and Kim (2014) Photothermally controlled gene delivery by reduced graphene oxide–polyethylenimine nanocomposite 10(1) (pp. 117-126) 10.1002/smll.201202636
  63. Chen et al. (2011) Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector 21(21) (pp. 7736-7741) 10.1039/c1jm10341e
  64. Pan et al. (2011) Water-soluble poly (N-isopropylacrylamide)–graphene sheets synthesized via click chemistry for drug delivery 21(14) (pp. 2754-2763) 10.1002/adfm.201100078
  65. Yang et al. (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide 112(45) (pp. 17554-17558) 10.1021/jp806751k
  66. Tang et al. (2009) Preparation, structure, and electrochemical properties of reduced graphene sheet films 19(17) (pp. 2782-2789) 10.1002/adfm.200900377
  67. Chang et al. (2010) Graphene fluorescence resonance energy transfer aptasensor for the thrombin detection 82(6) (pp. 2341-2346) 10.1021/ac9025384
  68. Tang et al. (2011) DNA-directed self-assembly of graphene oxide with applications to ultrasensitive oligonucleotide assay 5(5) (pp. 3817-3822) 10.1021/nn200147n
  69. Dong et al. (2010) Graphene as a novel matrix for the analysis of small molecules by MALDI-TOF MS 82(14) (pp. 6208-6214) 10.1021/ac101022m
  70. Wang et al. (2009) Application of graphene-modified electrode for selective detection of dopamine 11(4) (pp. 889-892) 10.1016/j.elecom.2009.02.013
  71. Chen et al. (2005) Self-assembly of synthetic hydroxyapatite nanorods into an enamel prism-like structure 288(1) (pp. 97-103) 10.1016/j.jcis.2005.02.064
  72. Zeng et al. (2010) Self-assembled graphene-enzyme hierarchical nanostructures for electrochemical biosensing 20(19) (pp. 3366-3372) 10.1002/adfm.201000540
  73. Shen et al. (2012) Biomedical applications of graphene 2(3) 10.7150/thno.3642
  74. Wan et al. (2010) Graphene oxide sheet-mediated silver enhancement for application to electrochemical biosensors 83(3) (pp. 648-653) 10.1021/ac103047c
  75. Khalil et al. (2017) Graphene metal nanocomposites—Recent progress in electrochemical biosensing applications (pp. 425-439) 10.1016/j.jiec.2017.11.001
  76. Ma et al. (2013) The layer-by-layer assembly of polyelectrolyte functionalized graphene sheets: a potential tool for biosensing (pp. 6-11) 10.1016/j.colsurfa.2013.02.039
  77. Fiorillo et al. (2015) Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via “differentiation-based nano-therapy” 6(6) 10.18632/oncotarget.3348
  78. Michaud et al. (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice 334(6062) (pp. 1573-1577) 10.1126/science.1208347
  79. Xu et al. (2007) Toll-like receptor 4 is a sensor for autophagy associated with innate immunity 27(1) (pp. 135-144) 10.1016/j.immuni.2007.05.022
  80. Levine (2005) Eating oneself and uninvited guests: autophagy-related pathways in cellular defense 120(2) (pp. 159-162)
  81. Chen et al. (2014) Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo 3(9) (pp. 1486-1495) 10.1002/adhm.201300591
  82. Liu et al. (2008) PEGylated nanographene oxide for delivery of water-insoluble cancer drugs 130(33) (pp. 10876-10877) 10.1021/ja803688x
  83. Yang et al. (2010) Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy 10(9) (pp. 3318-3323) 10.1021/nl100996u
  84. Markovic et al. (2011) In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes 32(4) (pp. 1121-1129) 10.1016/j.biomaterials.2010.10.030
  85. Kang et al. (2017) Gold nanoparticle/graphene oxide hybrid sheets attached on mesenchymal stem cells for effective photothermal cancer therapy 29(8) (pp. 3461-3476) 10.1021/acs.chemmater.6b05164
  86. Tian et al. (2011) Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide 5(9) (pp. 7000-7009) 10.1021/nn201560b
  87. de Faria et al. (2014) Anti-adhesion and antibacterial activity of silver nanoparticles supported on graphene oxide sheets (pp. 115-124) 10.1016/j.colsurfb.2013.08.006
  88. Das et al. (2011) Synthesis of silver nanoparticles in an aqueous suspension of graphene oxide sheets and its antimicrobial activity 83(z) (pp. 16-22) 10.1016/j.colsurfb.2010.10.033
  89. Bao et al. (2011) Synthesis and characterization of silver nanoparticle and graphene oxide nanosheet composites as a bactericidal agent for water disinfection 360(2) (pp. 463-470) 10.1016/j.jcis.2011.05.009
  90. Huang et al. (2015) An ultrasensitive electrochemical DNA biosensor based on graphene/Au nanorod/polythionine for human papillomavirus DNA detection (pp. 442-446) 10.1016/j.bios.2015.01.039
  91. Gulbakan et al. (2010) A dual platform for selective analyte enrichment and ionization in mass spectrometry using aptamer-conjugated graphene oxide 132(49) (pp. 17408-17410) 10.1021/ja109042w
  92. Geim (2009) Graphene: status and prospects 324(5934) (pp. 1530-1534) 10.1126/science.1158877
  93. Hu et al. (2018) Biomimetic graphene-based 3D scaffold for long-term cell culture and real-time electrochemical monitoring 90(2) (pp. 1136-1141) 10.1021/acs.analchem.7b03324
  94. Kalbacova et al. (2010) Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells 48(15) (pp. 4323-4329) 10.1016/j.carbon.2010.07.045
  95. Lee et al. (2018) When stem cells meet graphene: opportunities and challenges in regenerative medicine (pp. 236-250) 10.1016/j.biomaterials.2017.10.004
  96. Jasim et al. (2016) Synthesis of few-layered, high-purity graphene oxide sheets from different graphite sources for biology 3(1) 10.1088/2053-1583/3/1/014006
  97. Sasidharan et al. (2011) Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene 3(6) (pp. 2461-2464) 10.1039/c1nr10172b
  98. Li et al. (2013) Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites 110(30) (pp. 12295-12300) 10.1073/pnas.1222276110
  99. Ryoo et al. (2010) Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies 4(11) (pp. 6587-6598) 10.1021/nn1018279
  100. Fan et al. (2010) Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites 11(9) (pp. 2345-2351) 10.1021/bm100470q
  101. Qi et al. (2014) Layer-by-layer assembled graphene oxide composite films for enhanced mechanical properties and fibroblast cell affinity 2(3) (pp. 325-331) 10.1039/C3TB21387K
  102. Park et al. (2011) Enhanced differentiation of human neural stem cells into neurons on graphene
  103. Kim et al. (2015) Monolayer graphene-directed growth and neuronal differentiation of mesenchymal stem cells 11(11) (pp. 2024-2033) 10.1166/jbn.2015.2137
  104. Garcia-Alegria et al. (2016) Graphene oxide promotes embryonic stem cell differentiation to haematopoietic lineage 10.1038/srep25917
  105. Tyagi et al. (2013) Graphene nanomaterials and applications in bio-medical sciences 3(1) (pp. 339-345)
  106. Roy and Lee (2007) Biomedical applications of diamond-like carbon coatings: a review 83(1) (pp. 72-84) 10.1002/jbm.b.30768
  107. Huang et al. (2003) Hemocompatibility of titanium oxide films 24(13) (pp. 2177-2187) 10.1016/S0142-9612(03)00046-2
  108. Gillespie et al. (1988) The incidence of cancer following total hip replacement 70(4) (pp. 539-542) 10.1302/0301-620X.70B4.3403594
  109. Oryan et al. (2013) Current concerns regarding healing of bone defects 2(2) (pp. 1-12) 10.13172/2050-2303-2-2-374
  110. Rosa et al. (2012) Tissue engineering: from research to dental clinics 28(4) (pp. 341-348) 10.1016/j.dental.2011.11.025
  111. Amini et al. (2012) Bone tissue engineering: recent advances and challenges 10.1615/CritRevBiomedEng.v40.i5.10
  112. Stevens (2008) Biomaterials for bone tissue engineering 11(5) (pp. 18-25) 10.1016/S1369-7021(08)70086-5
  113. Lin et al. (2009) Study of hydroxyapatite osteoinductivity with an osteogenic differentiation of mesenchymal stem cells 89(2) (pp. 326-335) 10.1002/jbm.a.31994
  114. Mohandes and Salavati-Niasari (2014) In vitro comparative study of pure hydroxyapatite nanorods and novel polyethylene glycol/graphene oxide/hydroxyapatite nanocomposite 16(9) 10.1007/s11051-014-2604-y
  115. Mohandes and Salavati-Niasari (2014) Freeze-drying synthesis, characterization and in vitro bioactivity of chitosan/graphene oxide/hydroxyapatite nanocomposite 4(49) (pp. 25993-26001) 10.1039/c4ra03534h
  116. Liu et al. (2014) Biomimetic and cell-mediated mineralization of hydroxyapatite by carrageenan functionalized graphene oxide 6(5) (pp. 3132-3140) 10.1021/am4057826
  117. Liu et al. (2013) Synthesis of hydroxyapatite–reduced graphite oxide nanocomposites for biomedical applications: oriented nucleation and epitaxial growth of hydroxyapatite 1(13) (pp. 1826-1834) 10.1039/c3tb00531c
  118. Baradaran et al. (2014) Mechanical properties and biomedical applications of a nanotube hydroxyapatite-reduced graphene oxide composite (pp. 32-45) 10.1016/j.carbon.2013.11.054
  119. Nair et al. (2015) Graphene oxide nanoflakes incorporated gelatin–hydroxyapatite scaffolds enhance osteogenic differentiation of human mesenchymal stem cells 26(16) 10.1088/0957-4484/26/16/161001
  120. Xie et al. (2017) Graphene for the development of the next-generation of biocomposites for dental and medical applications 33(7) (pp. 765-774) 10.1016/j.dental.2017.04.008
  121. Gao et al. (2014) Enhancement mechanisms of graphene in nano-58S bioactive glass scaffold: mechanical and biological performance 10.1038/srep04712
  122. Li et al. (2017) Mechanical, tribological and biological properties of novel 45S5 Bioglass® composites reinforced with in situ reduced graphene oxide (pp. 77-89) 10.1016/j.jmbbm.2016.08.007
  123. Walker et al. (2011) Toughening in graphene ceramic composites 5(4) (pp. 3182-3190) 10.1021/nn200319d
  124. Lee et al. (2015) Reduced graphene oxide-coated hydroxyapatite composites stimulate spontaneous osteogenic differentiation of human mesenchymal stem cells 7(27) (pp. 11642-11651) 10.1039/C5NR01580D
  125. Xie et al. (2015) Two and three-dimensional graphene substrates to magnify osteogenic differentiation of periodontal ligament stem cells (pp. 266-275) 10.1016/j.carbon.2015.05.071
  126. Wu et al. (2015) Graphene-oxide-modified β-tricalcium phosphate bioceramics stimulate in vitro and in vivo osteogenesis (pp. 116-129) 10.1016/j.carbon.2015.04.048
  127. Lee et al. (2015) Enhanced osteogenesis by reduced graphene oxide/hydroxyapatite nanocomposites 10.1038/srep18833
  128. Rosa et al. (2013) Dental pulp tissue engineering in full-length human root canals 92(11) (pp. 970-975) 10.1177/0022034513505772
  129. Gunatillake and Adhikari (2003) Biodegradable synthetic polymers for tissue engineering 5(1) (pp. 1-16)
  130. Agrawal and Ray (2001) Biodegradable polymeric scaffolds for musculoskeletal tissue engineering 55(2) (pp. 141-150) 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
  131. Podila et al. (2013) Graphene coatings for biomedical implants
  132. Shradhanjali et al. (2017) Graphene for dental implant applications 7(36) (pp. 19876-19881)
  133. Segerström and Ruyter (2009) Adhesion properties in systems of laminated pigmented polymers, carbon–graphite fiber composite framework and titanium surfaces in implant suprastructures 25(9) (pp. 1169-1177) 10.1016/j.dental.2009.04.009
  134. Bartolo et al. (2012) Biomedical production of implants by additive electro-chemical and physical processes 61(2) (pp. 635-655) 10.1016/j.cirp.2012.05.005
  135. Yang et al. (2013) Nano-graphene in biomedicine: theranostic applications 42(2) (pp. 530-547) 10.1039/C2CS35342C
  136. Li et al. (2012) Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer’s disease 24(13) (pp. 1722-1728) 10.1002/adma.201104864
  137. Yao et al. (2016) Partially reduced graphene oxide based FRET on fiber-optic interferometer for biochemical detection 10.1038/srep23706
  138. Zhang et al. (2011) Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide 32(33) (pp. 8555-8561) 10.1016/j.biomaterials.2011.07.071
  139. Su et al. (2015) Efficient photothermal therapy of brain cancer through porphyrin functionalized graphene oxide 39(7) (pp. 5743-5749) 10.1039/C5NJ00122F
  140. You et al. (2012) Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors 72(18) (pp. 4777-4786) 10.1158/0008-5472.CAN-12-1003
  141. Yang et al. (2013) Graphene based materials for biomedical applications 16(10) (pp. 365-373) 10.1016/j.mattod.2013.09.004
  142. Zhou et al. (2011) Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro 17(43) (pp. 12084-12091) 10.1002/chem.201003078
  143. Kong and Huang (2014) Applications of graphene in mass spectrometry 14(7) (pp. 4719-4732) 10.1166/jnn.2014.9503
  144. Tang et al. (2010) Graphene-based SELDI probe with ultrahigh extraction and sensitivity for DNA oligomer 132(32) (pp. 10976-10977) 10.1021/ja104017y
  145. Zhou et al. (2010) Reduced graphene oxide films used as matrix of MALDI-TOF-MS for detection of octachlorodibenzo-p-dioxin 46(37) (pp. 6974-6976) 10.1039/c0cc01681k
  146. Lu et al. (2011) Matrix interference-free method for the analysis of small molecules by using negative ion laser desorption/ionization on graphene flakes 83(8) (pp. 3161-3169) 10.1021/ac2002559
  147. Zhang et al. (2013) Use of graphene as a matrix to minimize reduction in the process of matrix-assisted laser desorption/ionization 27(11) (pp. 1278-1282) 10.1002/rcm.6561
  148. Luo et al. (2011) Magnetic retrieval of graphene: extraction of sulfonamide antibiotics from environmental water samples 1218(10) (pp. 1353-1358) 10.1016/j.chroma.2011.01.022
  149. Lu et al. (2012) Facile synthesis of TiO2/graphene composites for selective enrichment of phosphopeptides 4(5) (pp. 1577-1580) 10.1039/c2nr11791f
  150. Kim and Min (2009) Durable large-area thin films of graphene/carbon nanotube double layers as a transparent electrode 25(19) (pp. 11302-11306) 10.1021/la9029744
  151. Kim and Min (2012) Preparation of the hybrid film of poly (allylamine hydrochloride)-functionalized graphene oxide and gold nanoparticle and its application for laser-induced desorption/ionization of small molecules 28(9) (pp. 4453-4458) 10.1021/la204185p
  152. Lee et al. (2010) Laser desorption/ionization mass spectrometric assay for phospholipase activity based on graphene oxide/carbon nanotube double-layer films 132(42) (pp. 14714-14717) 10.1021/ja106276j
  153. Kim et al. (2011) Synergistic effect of graphene oxide/MWCNT films in laser desorption/ionization mass spectrometry of small molecules and tissue imaging 5(6) (pp. 4550-4561) 10.1021/nn200245v
  154. Kim and Min (2012) Fabrication of alternating multilayer films of graphene oxide and carbon nanotube and its application in mechanistic study of laser desorption/ionization of small molecules 4(4) (pp. 2088-2095) 10.1021/am300054z
  155. Qian et al. (2013) Laser engineered graphene paper for mass spectrometry imaging 10.1038/srep01415
  156. Cheng et al. (2012) A graphene-based multifunctional affinity probe for selective capture and sequential identification of different biomarkers from biosamples 48(82) (pp. 10240-10242) 10.1039/c2cc35483g
  157. Liu et al. (2011) Graphene and graphene oxide sheets supported on silica as versatile and high-performance adsorbents for solid-phase extraction 123(26) (pp. 6035-6039) 10.1002/ange.201007138
  158. Shi et al. (2012) Enrichment and detection of small molecules using magnetic graphene as an adsorbent and a novel matrix of MALDI-TOF-MS 48(18) (pp. 2418-2420) 10.1039/c2cc17696c
  159. Zou et al. (2016) Mechanisms of the antimicrobial activities of graphene materials 138(7) (pp. 2064-2077) 10.1021/jacs.5b11411
  160. Chen et al. (2014) Graphene oxide exhibits broad-spectrum antimicrobial activity against bacterial phytopathogens and fungal conidia by intertwining and membrane perturbation 6(3) (pp. 1879-1889) 10.1039/C3NR04941H
  161. Solís-Fernández et al. (2017) Synthesis, structure and applications of graphene-based 2D heterostructures 46(15) (pp. 4572-4613) 10.1039/C7CS00160F